MTA is more than a CRO: MTA represents an academic-driven organisation for managing and coordinating local and full-scale clinical studies. We provide services for clinical trials in the pharmaceutical, biotechnology, nutritional and medical device industries. We work to provide excellent study data as quickly as possible for our sponsors through our depth of medical and scientific knowledge, innovative technology, professional expertise and proven good relationship with regulatory bodies

As an academic organisation, MTA clearly has significant advantages:

• Feasibility of study sites also through the network of the academic centres, which means a bigger choice of suitable patients and a better Investigators' reputation.
• Great flexibility in the overall organization of studies in Europe, Latin America and Asia from small, regional trials with a single site to large international phase III studies.
• Through its lay-out and congress facilities, MTA is fully available to place its expertise at the disposal of Medical Education learning systems, as is already the case with the University Institute for Higher Studies (IUSS), the University of Ferrara, and private partners and providers

In the last years, MTA developed in a significant manner the quality aspect both at the internal level (creating a tool for quality analysis and application) and at the external level (applying the knowledge for the performance of studies or offering it to our client). This achievement is an additional stone reinforcing the MTA basement and we are glad to be able now to offer our experience in this field.